electronic health recordNew products are expected to radically change the wearable fitness device game by allowing physicians and patients and even pathologists to see the same data
If Apple Inc. can succeed with its latest wearable health device, experts predict that physicians may soon begin using it to monitor the health of their patients. This may be auspicious for pathologists and clinical laboratory scientists if physicians ask them to monitor that patient data and provide consultative support.
It was in September when Apple (NASDAQ: AAPL) unveiled its new smartwatch. When combined with Apple’s HealthKit software platform, the Apple watch might well the most powerful wearable health-tracking device to hit the market yet. (more…)
Effort to do medical laboratory tests at point-of-care is not perfect, but the system did encourage 342 of the 573 drunks identified by the tests to take a ride home
In the world of point-of-care testing (POCT), this may be the most humorous attempt to perform medical laboratory testing in an unusual setting: the men’s toilet at a night club! As part of an anti-drunk driving campaign, a nightclub in Singapore has installed urine analyzers in urinals that automatically signal management when a patron is too drunk to drive.
Pathologists and clinical laboratory managers will find this initiative to not only be humorous, but instructive as to how innovative thinkers will apply diagnostic technologies in unorthodox ways. As used in Singapore, this program pairs the diagnostic testing device with an RFID chip and wireless technology to provide a real-time analysis and alert whenever the alcohol level of a customer participating in this program exceeds the legal limit for safe driving.
Pathologists and clinical laboratory managers may want to learn more about the UCheck mobile app developed by Biosense Technologies
Developers of a new iPhone application claim their app can analyze a urine specimen for up to 25 different diseases. This mobile app is a deliberate attempt to give consumers the ability to perform diagnostic tests that would normally be run in a full-scale clinical laboratory.
Pathologists and clinical biochemists will want to visit the website of Biosense Technologies to check out this mobile application, which is called uCheck. Biosense is a medical device company located in Mumbai, India. (more…)
QuantiaMD’s survey confirms that physicians will increasingly seek real-time connectivity and consultation with medical laboratory service providers
Physicians are quickly becoming fans of mobile computing. Clinical laboratory managers and pathologists will be interested to learn that, in fact, mobile computing is taking hold among physicians faster than in the general population.
This was one conclusion from a recent survey, according to an article in Healthcare Informatics. QuantiaMD, a Waltham, MA-based mobile and online physician community, conducted a survey of 3,798 physicians. More than 80 % of the respondents said they own a mobile device capable of downloading applications. That means that a far higher percentage of physicians are using mobile devices than among the general public.
Clinical laboratories and pathology groups may benefit from the attractive economics of digital marketing
For more than two decades, pharmaceutical sales representatives have been ubiquitous in doctors’ offices. But in a surprise development, many of the nation’s largest pharma companies are dramatically downsizing their sales forces and opting to promote their products through digital media.
This is an important new trend which has consequences for those clinical laboratories and anatomic pathology groups which send their own medical laboratory sales reps into doctors’ offices. It is evidence that the economics of sending sales reps into offices to educate and persuade physicians to prescribe new drugs for patients may be less favorable when compared to the economics of reaching physicians via the growing number of new digital sales and marketing channels.
In a recent story published by The Wall Street Journal, it was noted that pharmaceutical companies, as they reduce the number of sales reps who make calls on office-based physicians, increasingly make greater use of digital sales and marketing programs that include the Internet, smart phones, tablet technology and even iTunes.